Effect of temporary suspension of chronic immunosuppressive drugs on day-90 mortality and ICU-acquired infections among critically Ill patients with solid organ transplant: a retrospective multicenter study
Julien Vaidie(Centre Hospitalier Universitaire de Limoges), Bruno François(Inserm), Pierre Asfar(Centre Hospitalier Universitaire d'Angers), Pauline Guillot(Hôpital Pontchaillou), Boris Delange(Inserm), Bruno Evrard(Centre Hospitalier Universitaire de Clermont-Ferrand), Frédéric Pène(Centre National de la Recherche Scientifique), Anthony R. Gabriel(Hôpital Dupuytren), Jean-Claude Lachérade(Roche (France)), Piotr Szychowiak(Université d'Orléans), Ann A. Zalucky(University of Calgary), Philippe Vignon(Inserm), Julien Demiselle(Inserm), Edwige Péju(Centre National de la Recherche Scientifique), Antoine Guillon(Université de Tours)
Cited by 5
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
The SOFA score—development, utility and challenges of accurate assessment in clinical trials
|Critical Care|2019|976
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890